In this article, the team demonstrates the application of Alchemite™, a deep learning imputation method which underpins our Cerella™ technology, to physicochemical and sensory data. They compare the deep learning model with traditional QSAR models, demonstrating significantly improved accuracy using Cerella.
S. Mahmoud, B. Irwin, D. Chekmarev, S. Vyas, J. Kattas, T. Whitehead, T. Mansley, J. Bikker, G. Conduit, M. Segall,
J. Comput. Aided Mol. Des., 2021, 35(11), pp. 1125-1140
Find out more
You can read this publication on the journal webpage via the button below. Alternatively, find out more about the application of deep learning methods to sensory data in our webinar led by three authors of this paper, Samar Mahmoud and Tamsin Mansley (Optibrium) and Dmitriy Chekmarev (IFF).
INTERESTED IN AI FOR DRUG DISCOVERY?
Cerella™ is a unique artificial intelligence platform which supports medicinal chemists and other discovery scientists. It escalates success rates and advances small molecule drug discovery, from working with early hits to nominating preclinical candidates.
Cerella’s AI platform is proven to overcome limitations in drug discovery data, confidently delivering results and seamlessly integrating with your med chem software platforms.